Personalized Medicine in Ovarian Cancer: A Perspective From Mexico

Ovarian cancer (OC) represents a serious health problem worldwide. In Mexico, most OC patients are detected at late stages, consequently making OC one of the leading causes of death in women after reaching puberty. Personalized medicine (PM) provides an individualized therapeutic opportunity for tre...

Full description

Bibliographic Details
Main Authors: Fernández Garza, Luis E., Domínguez Vigil, Irma Guadalupe, Garza Martínez, José, Valdez Aparicio, Erick A., Barrera Barrera, Silvia A., Barrera Saldaña, Hugo Alberto
Format: Article
Language:English
Published: Elmer Press 2021
Subjects:
Online Access:http://eprints.uanl.mx/27187/7/27187.pdf.crdownload
_version_ 1824420678780059648
author Fernández Garza, Luis E.
Domínguez Vigil, Irma Guadalupe
Garza Martínez, José
Valdez Aparicio, Erick A.
Barrera Barrera, Silvia A.
Barrera Saldaña, Hugo Alberto
author_facet Fernández Garza, Luis E.
Domínguez Vigil, Irma Guadalupe
Garza Martínez, José
Valdez Aparicio, Erick A.
Barrera Barrera, Silvia A.
Barrera Saldaña, Hugo Alberto
author_sort Fernández Garza, Luis E.
collection Repositorio Institucional
description Ovarian cancer (OC) represents a serious health problem worldwide. In Mexico, most OC patients are detected at late stages, consequently making OC one of the leading causes of death in women after reaching puberty. Personalized medicine (PM) provides an individualized therapeutic opportunity for treating each patient relying on “omic” tools to match the correct drug with the specific pathogenic genomic signature. PM can help predict the best therapeutic option for each affected woman suffering from OC. In recent years, Mexico has made contributions to the PM of OC; however, it still has a long way to go for its full implementation in the country’s health system.
format Article
id eprints-27187
institution UANL
language English
publishDate 2021
publisher Elmer Press
record_format eprints
spelling eprints-271872024-12-09T18:06:52Z http://eprints.uanl.mx/27187/ Personalized Medicine in Ovarian Cancer: A Perspective From Mexico Fernández Garza, Luis E. Domínguez Vigil, Irma Guadalupe Garza Martínez, José Valdez Aparicio, Erick A. Barrera Barrera, Silvia A. Barrera Saldaña, Hugo Alberto RG Ginecología y Obstetricia Ovarian cancer (OC) represents a serious health problem worldwide. In Mexico, most OC patients are detected at late stages, consequently making OC one of the leading causes of death in women after reaching puberty. Personalized medicine (PM) provides an individualized therapeutic opportunity for treating each patient relying on “omic” tools to match the correct drug with the specific pathogenic genomic signature. PM can help predict the best therapeutic option for each affected woman suffering from OC. In recent years, Mexico has made contributions to the PM of OC; however, it still has a long way to go for its full implementation in the country’s health system. Elmer Press 2021 Article PeerReviewed text en cc_by_nc_nd http://eprints.uanl.mx/27187/7/27187.pdf.crdownload http://eprints.uanl.mx Fernández Garza, Luis E. y Domínguez Vigil, Irma Guadalupe y Garza Martínez, José y Valdez Aparicio, Erick A. y Barrera Barrera, Silvia A. y Barrera Saldaña, Hugo Alberto (2021) Personalized Medicine in Ovarian Cancer: A Perspective From Mexico. World Journal of Oncology, 12 (4). pp. 85-92. ISSN 1920-4531 http://doi.org/10.14740/wjon1383
spellingShingle RG Ginecología y Obstetricia
Fernández Garza, Luis E.
Domínguez Vigil, Irma Guadalupe
Garza Martínez, José
Valdez Aparicio, Erick A.
Barrera Barrera, Silvia A.
Barrera Saldaña, Hugo Alberto
Personalized Medicine in Ovarian Cancer: A Perspective From Mexico
thumbnail https://rediab.uanl.mx/themes/sandal5/images/online.png
title Personalized Medicine in Ovarian Cancer: A Perspective From Mexico
title_full Personalized Medicine in Ovarian Cancer: A Perspective From Mexico
title_fullStr Personalized Medicine in Ovarian Cancer: A Perspective From Mexico
title_full_unstemmed Personalized Medicine in Ovarian Cancer: A Perspective From Mexico
title_short Personalized Medicine in Ovarian Cancer: A Perspective From Mexico
title_sort personalized medicine in ovarian cancer a perspective from mexico
topic RG Ginecología y Obstetricia
url http://eprints.uanl.mx/27187/7/27187.pdf.crdownload
work_keys_str_mv AT fernandezgarzaluise personalizedmedicineinovariancanceraperspectivefrommexico
AT dominguezvigilirmaguadalupe personalizedmedicineinovariancanceraperspectivefrommexico
AT garzamartinezjose personalizedmedicineinovariancanceraperspectivefrommexico
AT valdezaparicioericka personalizedmedicineinovariancanceraperspectivefrommexico
AT barrerabarrerasilviaa personalizedmedicineinovariancanceraperspectivefrommexico
AT barrerasaldanahugoalberto personalizedmedicineinovariancanceraperspectivefrommexico